118 related articles for article (PubMed ID: 1036613)
1. Treatment of fibrocystic disease of the breast with a prolactin inhibitor: 2-Br-alpha-ergocryptine (CB-154).
Martin-Comin J; Pujol-Amat P; Cararach V; Davi E; Robyn C
Obstet Gynecol; 1976 Dec; 48(6):703-6. PubMed ID: 1036613
[TBL] [Abstract][Full Text] [Related]
2. [Antiprolactin therapy in the treatment of benign lesions of the breast. Comparison of bromocryptine and methergoline].
Mussa A; Sandrucci S; Dogliotti L
Minerva Med; 1979 Nov; 70(51):3493-8. PubMed ID: 522987
[TBL] [Abstract][Full Text] [Related]
3. Treatment of benign fibrocystic disease of the breast with 2-bromo-alpha-ergocryptine (CB 154).
Santoro C; Cappa M; Moretti C; Fabbri A; La Vecchia V; Romano Marcellino L; Fraioli F
Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):479-81. PubMed ID: 6815107
[TBL] [Abstract][Full Text] [Related]
4. Effect of 2 br-alpha-ergocryptin (CB 154) on serum prolactin and the clinical picture in a case of progressive gigantomastia in pregnancy.
Kullander S
Ann Chir Gynaecol; 1976; 65(4):227-33. PubMed ID: 970897
[TBL] [Abstract][Full Text] [Related]
5. [Neuroendocrine aspects of Parkinson's disease. Therapeutic/effect of a prolactin inhibitor].
Agnoli A; Casacchia M; Carolei A; Meco G; Zamponi A; Ruggieri S
Minerva Med; 1976 Nov; 67(53):. PubMed ID: 1036612
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of mastodynia with the prolactin inhibitor bromocryptine (CB 154).
Schulz KD; Del Pozo E; Lose KH; Künzig HJ; Geiger W
Arch Gynakol; 1975 Dec; 220(1):83-7. PubMed ID: 1243527
[TBL] [Abstract][Full Text] [Related]
7. Treatment of benign breast disease with bromocriptine.
Mussa A; Dogliotti L
J Endocrinol Invest; 1979; 2(1):87-91. PubMed ID: 489922
[TBL] [Abstract][Full Text] [Related]
8. [Successful treatment of galactorrhea, anemorrhea and infertility with a new ergot alkaloid (2-Br-alpha-ergocryptine)].
Schellekens LA; Roland R; Lequin RM
Ned Tijdschr Geneeskd; 1975 Apr; 119(14):541-7. PubMed ID: 1170514
[No Abstract] [Full Text] [Related]
9. [Bromocriptine in fibro-cystic mastopathy].
Marzetti L; Framarino ML; Dei Malatesta ML; Aragona C; De Angelis R
Riv Ital Ginecol; 1980; 59(4-5):357-64. PubMed ID: 7313397
[No Abstract] [Full Text] [Related]
10. Effect of bromocriptine and chlorotrianisene on inhibition of lactation and serum prolactin. A comparative double-blind study.
Utian WH; Begg G; Vinik AI; Paul M; Shuman L
Br J Obstet Gynaecol; 1975 Sep; 82(9):755-9. PubMed ID: 1101946
[TBL] [Abstract][Full Text] [Related]
11. Serum prolactin levels in patients with fibrocystic breast disease.
Peters F; Schuth W; Scheurich B; Breckwoldt M
Obstet Gynecol; 1984 Sep; 64(3):381-5. PubMed ID: 6431348
[TBL] [Abstract][Full Text] [Related]
12. Prolactin response to thyrotropin-releasing hormone as a guideline for cyclical mastalgia treatment.
Rea N; Bove F; Gentile A; Parmeggiani U
Minerva Med; 1997 Nov; 88(11):479-87. PubMed ID: 9433398
[TBL] [Abstract][Full Text] [Related]
13. Benign breast disease.
Mauvais-Jarvis P; Kuttenn F
Curr Ther Endocrinol Metab; 1994; 5():364-70. PubMed ID: 7704754
[No Abstract] [Full Text] [Related]
14. Metaclopramide and prolactin secretion in man: effects of pretreatment with L-dopa and 2-bromo-alpha-ergocryptine (CB-154).
Delitala G; Masala A; Alagna S; Devilla L
IRCS J Med Sci; 1975 Jun; 3(6):274. PubMed ID: 1165172
[No Abstract] [Full Text] [Related]
15. [Prolactin in serum and anamnestic data of women with cystic disease of the breast (author's transl)].
Bischoff J; Rebhan EM; Prestele H; Becker H
Geburtshilfe Frauenheilkd; 1980 Jan; 40(1):65-71. PubMed ID: 7353778
[TBL] [Abstract][Full Text] [Related]
16. Endocrine aspects of benign breast disease.
Parlati E; Liberale I; Travaglini A; Morelli P; Menini E; Dell'Acqua S
Cancer Detect Prev; 1992; 16(1):25-6. PubMed ID: 1312904
[TBL] [Abstract][Full Text] [Related]
17. Metergoline as an inhibitor of prolactin release.
Caballero A; Mena P; Caballero-Díaz JL; Caballero-Asensi A
J Reprod Med; 1987 Feb; 32(2):115-9. PubMed ID: 3560070
[TBL] [Abstract][Full Text] [Related]
18. ["Use of bromocriptin (CB 154) in the treatment of puerperal and pathological lactation" (author's transl)].
del Pozo E
Schweiz Rundsch Med Prax; 1976 Feb; 65(7):181-5. PubMed ID: 1250831
[No Abstract] [Full Text] [Related]
19. Serum prolactin levels of rats under continuous estrogen stimulation and 2 Br-alpha-ergocryptine (CB-154) injection.
Gala RR; Boss RS
Proc Soc Exp Biol Med; 1975 Jun; 149(2):330-2. PubMed ID: 1153405
[TBL] [Abstract][Full Text] [Related]
20. Circadian variation of serum prolactin and TSH of women in health or with mammary carcinoma, fibroadenoma or fibrocystic mastopathy.
Tarquini B; Gheri R; Romano S; Costa A; Cagnoni M; Lee JK; Halberg F
Int J Chronobiol; 1980; 7(2):101-15. PubMed ID: 7450919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
